A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Healthy Male and Female Japanese Volunteers

Interventions

DRUG

NXL104

IV Solution

DRUG

CAZ104

IV Solution

DRUG

Placebo

IV saline

Trial Locations (2)

Research Site, Glendale

Research Site, Baltimore